Gross Profit Margin (Quarterly) Chart

View Gross Profit Margin (Quarterly) for SIBN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Gross Profit Margin (Quarterly) Chart
Start Trial

Historical Gross Profit Margin (Quarterly) Data

View and export this data back to 2014. Start Trial.
Date Value
June 30, 2026 79.54%
March 31, 2026 79.76%
December 31, 2025 79.03%
September 30, 2025 79.84%
June 30, 2025 79.80%
March 31, 2025 79.71%
December 31, 2024 79.13%
September 30, 2024 79.09%
June 30, 2024 79.00%
March 31, 2024 78.87%
December 31, 2023 73.80%
September 30, 2023 79.30%
June 30, 2023 81.03%
March 31, 2023 81.89%
December 31, 2022 84.07%
September 30, 2022 84.23%
June 30, 2022 86.46%
March 31, 2022 86.71%
December 31, 2021 86.62%
September 30, 2021 88.88%
June 30, 2021 89.30%
March 31, 2021 89.24%
Date Value
December 31, 2020 89.73%
September 30, 2020 87.35%
June 30, 2020 84.93%
March 31, 2020 88.51%
December 31, 2019 89.67%
September 30, 2019 89.93%
June 30, 2019 90.27%
March 31, 2019 89.82%
December 31, 2018 91.15%
September 30, 2018 90.88%
December 31, 2017 91.15%
September 30, 2017 88.63%
June 30, 2017 89.81%
March 31, 2017 87.45%
March 31, 2016 87.98%
September 30, 2015
June 30, 2015
March 31, 2015 82.84%
December 31, 2014 78.66%
September 30, 2014
June 30, 2014
March 31, 2014 88.55%

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Range, Past 5 Years

View Gross Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit Margin (Quarterly) Benchmarks

View Gross Profit Margin (Quarterly) Benchmarks
Start Trial
Abbott Laboratories 52.64%
AngioDynamics, Inc. 50.87%
Alphatec Holdings, Inc. 62.90%
AtriCure, Inc. 76.75%
Baxter International, Inc. 33.55%

Gross Profit Margin (Quarterly) Related Metrics